Pricing Log in Create free account
Saturday 17 October 2026 Export YTENQ’s income statement to Excel — free account

Metabolix, Inc.

YTENQ Basic Materials Agricultural Inputs

Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$1.5M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
2/9
Altman Z
−161.45
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 12.77%

Capital & Financial Ratios $m

Market Cap 1.52
Revenue 0.90
Net Income (12.70)
Free Cash Flow (5.80)
Net Debt (0.73)
Current Ratio 0.16 (below 1: weak)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E (0.12) (negative: loss-making)
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 58.52% (at or above 15%: strong)
Next Y EPS Growth (12.58%) (below 0%: weak)
Next Y revenue growth 1,900.00% (at or above 10%: strong)
Next 5Y EPS Growth 0.00%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.3×, against a ten-year median of 6.5×; over the ten years it ranged from −9.0× in 2018 to 61.8× in 2016.
EV/Sales against its own 10 years 14.00%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2021 2022 2023 Q'24
Cash 16 4 1 1
Receivables 0 0 — —
Inventory — — — —
Other — — — —
17 5 1 1
2021 2022 2023 Q'24
Payables 0 0 1 2
ST’ Debt — — — —
Other — — — —
2 2 5 8

Compound Annual Growth %

10y 5y 3y
Sales (33.92%) (35.94%) (57.81%)
Cash Flow 0.00% 0.00% 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value 0.00% 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 0 0 — — —
’23 0 — — — 0
’22 0 0 0 0 0
’21 0 0 0 0 1
’20 0 0 0 0 1
’19 0 0 0 0 1
’18 0 0 0 0 1
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) (1) — — —
’23 (3) (3) (3) (2) (10)
’22 (3) (3) (3) (3) (11)
’21 (3) (2) (2) (2) (9)
’20 (2) (2) (2) (2) (9)
’19 (2) (2) (1) (3) (9)
’18 (3) (2) (2) (2) (9)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) (1) — — —
’23 (3) (3) (3) (2) (10)
’22 (3) (3) (3) (3) (12)
’21 (3) (2) (2) (3) (9)
’20 (2) (2) (2) (2) (9)
’19 (2) (2) (1) (3) (9)
’18 (3) (2) (2) (2) (9)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (4.77) (5.04) — — —
’23 (18.22) (15.35) (9.83) (6.47) (43.64)
’22 (16.31) (16.79) (17.03) (16.07) (66.19)
’21 (14.39) (15.35) (11.75) (14.63) (55.87)
’20 (50.84) (22.06) (20.86) (18.94) (103.12)
’19 (211.03) (143.88) (153.48) (349.49) (851.32)
’18 (230.22) (230.22) (249.40) (182.25) (882.49)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 Trend 2024e 2025e 2026e
Price, $
Price, $ Low — — 2,400.00 1,699.20 652.80 107.42 84.00 95.52 39.12 4.32

Analyst estimates 2024–2026

Powerpack
High — — 21,983.99 8,928.00 2,976.00 1,696.90 352.56 563.76 173.04 100.56
People
People Employees — — 20 20 22 25 25 29 30 29
Revenue/emp, $m — — 0.06 0.05 0.03 0.03 0.03 0.02 0.02 0.00
Income, $m
Income, $m Revenue — — 1 1 1 1 1 1 0 0
Gross margin, % — — 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
EBT — — (10) (9) (9) (13) (10) (11) (13) (14)
EBT margin, % — — (887.49) (995.34) (1,651.98) (1,638.96) (1,270.34) (1,790.72) (2,980.00) (24,091.67)
Net income — — (8) (9) (9) (13) (10) (11) (14) (14)
Depreciation — — 1 0 0 0 0 0 0 0
Per share, $
Per share, $ Revenue — — 399.66 277.65 53.46 53.03 8.07 3.11 2.20 0.18
Earnings — — (2,589.93) (3,155.87) (882.49) (851.32) (103.12) (55.87) (66.19) (43.64)
Cash flow — — (4,966.90) (2,412.35) (841.73) (569.34) (87.46) (46.90) (55.63) (30.39)
Capex — — (259.31) (1.76) (4.04) (4.01) (0.67) (0.96) (0.75) (0.14)
Free cash flow — — (5,226.21) (2,414.12) (845.77) (573.36) (88.13) (47.86) (56.38) (30.53)
Book value — — 2,196.21 3,971.18 547.88 (268.75) 96.28 81.23 21.46 (7.49)
Shares, m — — 0 0 0 0 0 0 0 0
Valuation, ×
Valuation, × P/E — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — 8.43 7.09 14.90 3.10 17.19 37.94 18.70 5.54
P/B — — 1.53 0.53 1.45 0.00 1.44 1.45 1.91 0.00
EV/Sales — — 3.10 (7.16) 14.64 (6.20) 9.00 16.22 13.65 5.27
EV/FCF — — (0.24) 0.79 (0.93) 0.57 (0.82) (1.05) (0.53) (0.19)
Cash, $m
Cash, $m Operating cash flow — — (14) (8) (9) (9) (9) (9) (11) (10)
Capex — — (1) 0 0 0 0 0 0 0
Free cash flow — — (15) (8) (9) (9) (9) (9) (12) (10)
Balance, $m
Balance, $m Working capital — — 5 13 5 9 9 15 3 (3)
Total debt — — 1 — 6 4 3 3 2 —
Net debt — — (6) (14) (6) (11) (10) (16) (4) (1)
Shareholders’ equity — — 6 14 6 (4) 10 16 4 (2)
Returns, %
Returns, % ROA — — (54.63) (78.34) (61.56) (87.31) (65.34) (63.15) (95.20) (241.08)
ROIC — — (3,335.94) 0.00 0.00 0.00 0.00 (20,298.61) (15,862.03) 0.00
ROE — — (78.40) (113.61) (99.93) (1,606.45) (374.74) (86.32) (132.83) (1,508.09)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2023 · latest quarter Jun 2024

Charts ten years each

Metabolix, Inc. vs peers in Agricultural Inputs (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AVD American Vanguard Corporation $36.9M — (loss-making) 11.4× −9.71% (below 0%: shrinking) n/m −33.18% (below 0%: shrinking) 29.73% (0.26%) Compare
LVROF Lavoro Limited $34.8M — (loss-making) — (loss-making) −23.62% (below 0%: shrinking) n/m −6.85% (below 0%: shrinking) 15.65% 0.67% Compare
BIOX Bioceres Crop Solutions Corp. $18.6M — (loss-making) 27.0× −34.73% (below 0%: shrinking) n/m +344.29% (above 0%: growing) 32.23% (10.91%) Compare
SEED Origin Agritech Limited $8.9M — (loss-making) — (loss-making) +432.86% (above 0%: growing) n/m −107.51% (below 0%: shrinking) 22.38% 0.00% Compare
ENFY Enlightify Inc. $1.8M — (loss-making) — −16.73% (below 0%: shrinking) n/m +48.84% (above 0%: growing) 23.90% 8.21% Compare
YTENQ Metabolix, Inc. $1.5M — (loss-making) — (loss-making) +305.41% (above 0%: growing) n/m +81.47% (above 0%: growing) 100.00% (711.78%)
BHILQ Benson Hill, Inc. $1.5M — (loss-making) — (loss-making) +45.32% (above 0%: growing) n/m +56.10% (above 0%: growing) (1.34%) (57.94%) Compare
NXTS Nexentis Technologies Inc. $990.0K 0.0× — (loss-making) −4,244.44% (below 0%: shrinking) n/m −2.86% (below 0%: shrinking) 100.00% 502.68% Compare
SANW S&W Seed Company $760.0K — (loss-making) — (loss-making) +1.97% (above 0%: growing) n/m +39.42% (above 0%: growing) 37.74% (6.94%) Compare
Median of peers $5.4M — — −13.22% — +18.28% 26.82% (0.13%)

All 18 Agricultural Inputs stocks →

Metabolix, Inc. (YTENQ) key facts

  • Concern: Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022.
  • Metabolix, Inc. (YTENQ) is an Agricultural Inputs company in the Basic Materials sector.
  • Return on equity was −1,508.1% and debt-to-equity 0.00.
  • Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −161.45 (distress zone) for fiscal 2023.

Source: company filings (standardised) and stockrow calculations.

Metabolix, Inc. (YTENQ) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/YTENQ · Data as of Jun 30, 2024 · For information only; not investment advice. · © 2026 stockrow.com